Sign In
Buy ISRG
$350.06
-3.11 (-0.88%)
At Close: Jul 21, 2026
Trump's Tariffs Could Impact This Top Growth Stock. Here's Why It's Still a Buy
05:30am, Thursday, 01'st May 2025
President Donald Trump's macroeconomic policies are creating significant uncertainty. His decision to impose sweeping tariffs on goods imported into the U.S. could harm the economy and specific corpor
Baron Health Care Fund Q1 2025 Top Net Purchases And Sales
11:45am, Tuesday, 29'th Apr 2025
Initiated positions in Waters Corporation, Penumbra, McKesson, Masimo, and added to UnitedHealth Group due to strong market positions and growth potential. Waters Corporation's growth driven by biopha
Baron Health Care Fund Q1 2025 Top Contributors And Detractors
11:30am, Tuesday, 29'th Apr 2025
Boston Scientific's shares rose due to strong market growth, innovative products like pulsed field ablation, and disciplined cost management, driving double-digit EPS growth. Vertex Pharmaceuticals sa
ISRG vs. SYK: Which Robotic-Device Innovator Is a Better Buy?
10:15am, Tuesday, 29'th Apr 2025
As robotic-assisted surgery becomes a cornerstone of modern healthcare, two medtech giants — Intuitive Surgical ISRG and Stryker SYK — are leading the charge. Intuitive, the pioneer behind the da
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know
10:01am, Tuesday, 29'th Apr 2025
Zacks.com users have recently been watching Intuitive Surgical (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
2 Growth Stocks to Buy on the Dip if the Market Crashes Again
02:28pm, Saturday, 26'th Apr 2025
Anxious investors who picked April to go on a long internet-free vacation couldn't have planned it better. Earlier this month, the S&P 500 index quickly sank more than 10% after President Donald Trump
Trade Tracker: Stephanie Link buys Intuitive Surgical
01:03pm, Friday, 25'th Apr 2025
Stephanie Link, CIO at Hightower, joins CNBC's "Halftime Report" to detail her latest buy of Intuitive Surgical
Is Intuitive Surgical a Buy After Volatile Reaction to Earnings?
08:16am, Friday, 25'th Apr 2025
Shares of Intuitive Surgical Inc. NASDAQ: ISRG are leveling off after some volatile price movement around the company's quarterly earnings. On April 22, the robotics surgery company delivered a beat
Intuitive Surgical: Decent Results But Waiting For An Entry Point
07:27am, Friday, 25'th Apr 2025
Intuitive Surgical's Q1 2025 earnings showed mixed results, with revenue and EPS beating expectations, but gross margins impacted by tariffs and a lower-margin product mix. Procedure volume growth was
Is Intuitive Surgical Stock a Buy?
04:10am, Thursday, 24'th Apr 2025
Intuitive Surgical (ISRG 2.05%) has rewarded long-term investors by climbing nearly 200% over the past five years. This is thanks to the company's leadership in a hot growth area: robotic surgery.
Analysts Remain Bullish On Intuitive Surgical Despite Macro Uncertainty
04:59pm, Wednesday, 23'rd Apr 2025
Intuitive Surgical Inc ISRG reported first-quarter 2025 revenue of $2.25 billion, beating analyst estimates of $2.19 billion.
ISRG Stock Falls Despite Q1 Earnings Beat, Gross Margin Contracts
01:40pm, Wednesday, 23'rd Apr 2025
ISRG's first-quarter results reflect a healthy demand for procedures on higher system utilization. However, tariffs lead to a decline in the gross margin outlook.
These Analysts Lower Their Forecasts On Intuitive Surgical After Q1 Earnings
01:06pm, Wednesday, 23'rd Apr 2025
Intuitive Surgical Inc ISRG reported better-than-expected first-quarter financial results Tuesday after the bell.
Intuitive Surgical Stock Is Surging. Tariffs Could Be Less of a Threat.
10:24am, Wednesday, 23'rd Apr 2025
Surgical robots firm Intuitive Surgical said exports to and imports from China are subject to high tariffs. Shares are rising Wednesday on hopes the trade war will de-escalate.
Intuitive Surgical, Inc. (ISRG) Q1 2025 Earnings Call Transcript
08:32pm, Tuesday, 22'nd Apr 2025
Intuitive Surgical, Inc. (NASDAQ:ISRG ) Q1 2025 Earnings Conference Call April 22, 2025 4:30 AM ET Company Participants Dan Connally - Head of IR Gary Guthart - CEO David Rosa - President Jamie Samath
